American Psychiatric Association's Survey Reveals Public Perception of Safety and Addictiveness of Cannabis and Other Substances
The American Psychiatric Association released results from their annual survey on addictive substances and behaviors.
In a news release from June 8, 2023, the American Psychiatric Association (APA) discussed results from its national survey on Americans’ usage of and opinions on cigarettes, alcohol, opioids, vapes, technology, and cannabis (1). Over 2200 Americans were polled in April of 2023 by APA and Morning Consult, which is part of APA’s Healthy Minds Monthly regular polls (1).
According to one section of the results, cigarettes were viewed as a very or somewhat addictive substance/behavior by 87% of respondents, followed by alcohol (84%) and prescribed opioids (83%) (1). Comparatively, cannabis/marijuana was considered by 64% to be very or somewhat addictive (1).
Out of the 2200 respondents, 38% said cannabis was very or somewhat unsafe, and 13% said they used it daily (1). Only technology was seen a safer substance, and 67% said they used it daily (1). Cigarettes were reported by the most respondents as very or somewhat unsafe (84%) (1).
According to its website, APA was founded in 1844 and currently has more than 38,000 physician members (1).
Reference
- New APA Poll finds Americans rate cigarettes as most unsafe, addictive substance among options surveyed https://www.psychiatry.org/News-room/News-Releases/New-APA-Poll-Finds-Americans-Rate-Cigarettes-as-Mo (accessed Jun 14, 2023).
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
